Amicus Therapeutics Inc

NASDAQ:FOLD   4:00:00 PM EDT
12.25
-0.12 (-0.97%)
7:14:59 PM EDT: $12.13 -0.12 (-0.98%)
Earnings Announcements

Amicus Therapeutics Reports Q3 Loss Per Share Of $0.12

Published: 11/07/2022 12:31 GMT
Amicus Therapeutics Inc (FOLD) - Amicus Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Updates.
Amicus Therapeutics Inc- Updating Full-year 2022 Non-GAAP Operating Expense Guidance From $470m-$485m to $430m-$440m.
Amicus Therapeutics Inc - Qtrly Loss per Share $0.12.
Revenue is expected to be $86.38 Million
Adjusted EPS is expected to be -$0.12

Next Quarter Revenue Guidance is expected to be $90.89 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.